The answer to cancer may be walking beside us

Posted: Sep 27, 2016

Rocky Mountain PBS will air a new documentary this Thursday, Sept. 29 at 9 p.m. called, “The answer to cancer may be walking beside us.” This documentary features Amy LeBlanc, Director of the Comparative Oncology Program, Mark Simpson, Senior Scientist in the Laboratory of Cancer Biology and Genetics, and Chand Khanna, former CCR Senior Scientist. Using animals to study cancer goes hand-in-hand with the Cancer Moonshot goals of accelerating cancer research and making more therapies available to more patients. Vice President Joe Biden, who leads the initiative, says when it comes to cancer, “Time matters. Days matter. Minutes matter.”

The answer to cancer may be walking beside us
Meera in the lab

CCR celebrates National Postdoc Appreciation Week

Posted: Sep 27, 2016

National Postdoc Appreciation Week took place Sept. 19-23. Throughout the week, outstanding postdocs and training opportunities were featured on Twitter. We’ve recapped our coverage in this Storify post.

CCR celebrates National Postdoc Appreciation Week
Steven Pavletic, MD

Steven Pavletic discusses new strategies to target GVHD

Posted: Sep 23, 2016

Steven Pavletic, senior clinician in the Experimental Transplantation and Immunology Branch, discussed new strategies for treating graft-versus-host disease with OncLive. He says these new strategies are the result of improved understanding of the disease’s pathophysiology, and the new therapies could lead to less toxic and more effective therapies.  Learn more...

Steven Pavletic discusses new strategies to target GVHD

Six-year-old Jordan fights thyroid cancer with the help of the Pediatric Oncology Branch

Posted: Sep 15, 2016

Six-year-old Jordan van Tonder is originally from South Africa, but he comes to CCR’s Pediatric Oncology Branch every six months for thyroid cancer treatment. “He’s always excited about something. He is a great kid and makes me smile whenever I see him,” says Dr. John Glod, his physician and the study’s Principal Investigator.  Jordan is participating in a protocol for multiple endocrine neoplasia type 2b (MEN2B), a rare condition through which he developed thyroid cancer. Read more…

Six-year-old Jordan fights thyroid cancer with the help of the Pediatric Oncology Branch

Dr. Amy LeBlanc quoted in Proto magazine article

Posted: Sep 13, 2016

Dr. Amy LeBlanc, staff scientist and director of the Comparative Oncology Program, was quoted in a clinical research article in Proto Magazine. The article discusses comparative oncology and using dogs, who get cancer naturally like humans, for cancer research instead of mice, who get cancer artificially.

Dr. Amy LeBlanc quoted in Proto magazine article

NIH featured on Universum’s most attractive employers list

Posted: Sep 8, 2016

The NIH is now listed on Universum’s Most Attractive Employers list, and Andrea Apolo, principal investigator in CCR’s Genitourinary Malignancies Branch, is the NIH’s featured employee success story. She says she is in awe of the work that happens at the NCI and “translating biomedical research into clinical work is a dream come true.”  Learn more...

NIH featured on Universum’s most attractive employers list

Steven Rosenberg discusses immunotherapy on “What it Takes” podcast series

Posted: Sep 7, 2016

“His work is helping to revolutionize the way cancer will be treated in the future.” Steven Rosenberg, M.D., Ph.D., senior investigator and chief of the Surgery Branch, was recently featured on the Academy of Achievement’s “What it Takes” podcast series, which features “intimate, revealing conversations with towering figures in their fields.” In the episode, “Finding a cure for cancer,” Rosenberg tells the story of his journey and dogged determination in developing immunotherapy and “creating tomorrow’s medicine” to Pulitzer Prize-winning journalist Mary Jordan. We also hear from one of his patients.

Steven Rosenberg discusses immunotherapy on “What it Takes” podcast series

September is Childhood Cancer Awareness Month

Posted: Aug 26, 2016

In honor of our patients, their families, and caregivers, members of the Pediatric Oncology Branch will be talking a lot about childhood cancer research, treatment, prevention and survivorship during the month of September.  Our activities will kick off on September 1st with a live Google Hangout on Air.

Learn more...

September is Childhood Cancer Awareness Month

Waldmann discusses the "the second coming of daclizumab"

Posted: Aug 24, 2016

Dr. Waldmann, NIH Distinguished Investigator and Chief of the Lymphoid Malignancies Branch, discusses his 35-year odyssey with daclizumab.
Read more...

Waldmann discusses the "the second coming of daclizumab"
Sadhana Jackson, M.D.

Blood-brain barrier: the "Holy Grail' of neuro-oncology

Posted: Aug 24, 2016

"People like me say…we need to find a way…"  Sadhana Jackson, a physician researcher with the Neuro-Oncology Branch, discusses the challenges of delivering drug treatments to brain tumors in an interview with HemOnc Today. Read More...

Blood-brain barrier: the "Holy Grail' of neuro-oncology

Pages